Φορτώνει......
Inhibition of 5-lipoxygenase decreases renal fibrosis and progression of chronic kidney disease
In inflammatory diseases, the 5-lipoxygenase (5-LO) pathway contributes to epithelial damage and fibrosis by catalyzing the production of leukotrienes (LTs). Antagonists of the 5-LO pathway are currently approved for use in patients and are well tolerated. We found that expression of 5-LO is strongl...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Am J Physiol Renal Physiol |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
American Physiological Society
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6483031/ https://ncbi.nlm.nih.gov/pubmed/30649890 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajprenal.00262.2018 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|